BDX Becton Dickinson and Company

Becton, Dickinson and Company (BDX) is currently at $252.12, down $33.87 or 11.84%

-- Would be lowest close since Nov. 22, 2019, when it closed at $249.89

-- On pace for largest percent decrease since June 14, 1999, when it fell 22.4%

-- Earlier Thursday, Becton, Dickinson and Co. lowered its fiscal-year 2020 outlook as the company said it is continuing to work the Federal Drug Administration on its remediation plan for the Alaris System and is anticipating loss of sales of the Alaris infusion system. The company expects adjusted earnings of $11.90 a share to $12.10 a share. It previously expected adjusted earnings of $12.50 a share to $12.65 a share

-- The company also reported a first-quarter profit of $278 million, or 87 cents a share, compared with $599 million, or $2.05 a share, in the comparable quarter last year. Analysts polled by FactSet were looking for $2.16 a share

-- Snaps a three day winning streak

-- Down 7.3% year-to-date

-- Down 11.84% from its all-time closing high of $285.99 on Feb. 5, 2020

-- Traded as low as $241.75; lowest intraday level since Nov. 13, 2019, when it hit $240.61

-- Down 15.47% at today's intraday low; largest intraday percent decrease since June 14, 1999, when it fell as much as 24.48%

-- Worst performer in the S&P 500 today

All data as of 10:28:09 AM

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

February 06, 2020 10:53 ET (15:53 GMT)

Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Mar 2024 to Apr 2024

Becton Dickinson (NYSE:BDX)
Historical Stock Chart
From Apr 2023 to Apr 2024